Neurite dispersion: A new marker of multiple sclerosis spinal cord pathology? by Grussu, F et al.
RESEARCH ARTICLE
Neurite dispersion: a new marker of multiple sclerosis
spinal cord pathology?
Francesco Grussu1,2,a , Torben Schneider1,3,a, Carmen Tur1, Richard L. Yates4, Mohamed Tachrount5,
Andrada Ianus2, Marios C. Yiannakas1, Jia Newcombe6, Hui Zhang2, Daniel C. Alexander2,
Gabriele C. DeLuca4,b, & Claudia A. M. Gandini Wheeler-Kingshott1,7,8,b
1NMR Research Unit, Department of Neuroinflammation, Queen Square MS Centre, UCL Institute of Neurology, University College London,
London, United Kingdom
2Centre for Medical Image Computing, Department of Computer Science, University College London, London, United Kingdom
3Philips UK, Guildford, Surrey, United Kingdom
4Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
5Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, University College London, London, United Kingdom
6NeuroResource, UCL Institute of Neurology, University College London, London, United Kingdom
7Brain MRI 3T Mondino Research Centre, C. Mondino National Neurological Institute, Pavia, Italy
8Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy
Correspondence
Claudia A. M. Gandini Wheeler-Kingshott,
Professor of MR Physics, UCL Institute of
Neurology, University College London, Russell
Square House, 10-12 Russell Square, London
WC1B 5EH, United Kingdom. Tel: +44(0)
2031087425; E-mail: c.wheeler-
kingshott@ucl.ac.uk
Gabriele C. DeLuca, Associate Professor,
Nuffield Department of Clinical
Neurosciences, University of Oxford, John
Radcliffe Hospital, Oxford OX3 9DU,




This work was supported by: UCL Grand
Challenges scheme, Horizon 2020
Framework Programme (H2020)-EU.3.1 CDS-
QUAMRI (634541) grant, Engineering and
Physical Sciences Research Council (EPSRC)
Platform Grant for medical image computing
for next-generation healthcare technology
(EP/M020533/1) (funding F.G.); UK Multiple
Sclerosis Society (892/08) and the
Department of Health’s National Institute for
Health Research (NIHR) Biomedical Research
Centres (BRC R&D03/10/RAG0449)
(supporting the NMR Unit); 2015 European
Committee for Research and Treatment in
Multiple Sclerosis (ECTRIMS) post-doctoral
research fellowship (funding C.T.); EPSRC
(funding A.I.; grant M507970); UK Multiple
Sclerosis Society (funding M.C.Y.). D.C.A.
receives research funding from the EPSRC
(G007748, I027084, M020533, N018702)
and H2020-EU.3.1 (634541, 666992-2);
Abstract
Objective: Conventional magnetic resonance imaging (MRI) of the multiple
sclerosis spinal cord is limited by low specificity regarding the underlying
pathological processes, and new MRI metrics assessing microscopic damage are
required. We aim to show for the first time that neurite orientation dispersion
(i.e., variability in axon/dendrite orientations) is a new biomarker that uncovers
previously undetected layers of complexity of multiple sclerosis spinal cord
pathology. Also, we validate against histology a clinically viable MRI technique
for dispersion measurement (neurite orientation dispersion and density imaging,
NODDI), to demonstrate the strong potential of the new marker. Methods: We
related quantitative metrics from histology and MRI in four post mortem spinal
cord specimens (two controls; two progressive multiple sclerosis cases). The
samples were scanned at high field, obtaining maps of neurite density and ori-
entation dispersion from NODDI and routine diffusion tensor imaging (DTI)
indices. Histological procedures provided markers of astrocyte, microglia, mye-
lin and neurofilament density, as well as neurite dispersion. Results: We report
from both NODDI and histology a trend toward lower neurite dispersion in
demyelinated lesions, indicative of reduced neurite architecture complexity.
Also, we provide unequivocal evidence that NODDI-derived dispersion matches
its histological counterpart (P < 0.001), while DTI metrics are less specific and
influenced by several biophysical substrates. Interpretation: Neurite orientation
dispersion detects a previously undescribed and potentially relevant layer of
microstructural complexity of multiple sclerosis spinal cord pathology. Clini-
cally feasible techniques such as NODDI may play a key role in clinical trial
and practice settings, as they provide histologically meaningful dispersion
indices.
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Multiple sclerosis is a central nervous system disease char-
acterized by a complex pathophysiology,1 the fundamental
features of which have been derived from the analysis of
post mortem tissue.2–5 Spinal cord pathology is an impor-
tant determinant of permanent neurological disability
with cardinal characteristics being inflammatory demyeli-
nation, synaptic, neuronal and axonal loss.6–11 The precise
nature of how these pathological alterations impact clini-
cal phenotypes remains unknown.
Conventional magnetic resonance imaging (MRI) pro-
vides the unique opportunity to decipher the impact of
multiple sclerosis spinal cord pathology on clinical out-
comes in vivo. However, the pathological substrate of
radiological changes are relatively nonspecific and fail to
consistently correlate with measures of disability.12 New
quantitative MRI methods that assess functionally relevant
microstructure noninvasively and relate to changes at the
microscopic level are urgently needed.
Quantitative MRI offers promising metrics that may
provide higher specificity and sensitivity to early and dif-
fuse microscopic damage,13 potentially overcoming the
radiological-clinical paradox14 (i.e., the poor association
between clinical findings and extent of radiological
involvement). In vivo mapping of myelin density15 and g-
ratio16; iron deposition17; sodium concentration18; inflam-
mation and axonal injury19 are examples of quantitative
MRI techniques being developed to detect early multiple
sclerosis pathology. Similar quantitative MRI metrics
require extensive validation, in order to confirm their
specificity and relevance to clinical outcomes.20–22.
A heretofore neglected but potentially functionally rele-
vant morphological feature of neural tissue is the com-
plexity of the orientations of axons and dendrites,
collectively known as neurites. Neurites allow the
exchange of information among neurons, and there is evi-
dence to believe that changes of their architecture can
impact directly on neural function.23 Alteration of den-
drite morphology could account per se for impairment
beyond mere neuronal death.24 In multiple sclerosis, pri-
mary morphological changes have been recently detected
at the level of the dendritic spines and branches.25 These
findings suggest that mapping neurite morphology in
multiple sclerosis is of high interest, as it can potentially
provide novel insights about pathophysiology and better
explain motor, sensory and cognitive deficits often
encountered in the disease.
In this study, we aim to show that neurite orientation
dispersion, namely the variability of neurite orientations,
is a new sensitive and specific biomarker of multiple scle-
rosis spinal cord pathology. Furthermore, we aim to vali-
date neurite orientation dispersion and density imaging
(NODDI), a recent model-based diffusion MRI tech-
nique.26 The clinical feasibility of NODDI in vivo has
already been demonstrated,26–29 and here we compare
NODDI dispersion indices against histology to demon-
strate that the new marker has strong clinical potential.
NODDI belongs to the family of quantitative MRI meth-
ods, and unlike conventional radiographic readouts its
metrics are designed to measure features of tissue
microstructure at a length scale that is orders of magni-
tude smaller than the size of the imaging voxels. Through
the combination of state-of-the-art quantitative histology
with post mortem NODDI imaging, we measure for the
first time a trend toward reduced orientation dispersion
(i.e., reduced geometrical complexity of neurite architec-
ture) in multiple sclerosis demyelinated lesions. Moreover,
we demonstrate that NODDI orientation dispersion index
is histologically meaningful. Our work suggests that
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neurite dispersion characterizes the complexity of pathol-
ogy at a new microstructural level that may provide
important insight into the pathophysiological processes
driving irreversible disability in multiple sclerosis.
Materials and Methods
Specimens
Formalin-fixed post mortem tissue from the upper tho-
racic and upper lumbar spinal cord of two nonneurologi-
cal disease controls (thoracic: 66-year-old male, length:
3.1 cm; lumbar: 67-year-old female, length: 2.1 cm) and
two multiple sclerosis (thoracic: 75-year-old male, decease
secondary to primary progressive multiple sclerosis,
length: 3.3 cm; lumbar: 67-year-old female, decease sec-
ondary to secondary progressive multiple sclerosis, length:
2.4 cm) tissue donors was used (samples obtained from
Oxford Brain Bank and UCL NeuroResource tissue bank).
Donation followed written informed consent and the
material was processed according to Human Tissue
Authority guidelines, after Ethical Approvals by appropri-
ate review boards. Samples were stored in 10% formalin
and washed for 24 h in 10 mmol/L phosphate buffered
saline solution for downstream imaging. Subsequently,
each sample was cut in the mid-sagittal plane to allow for
accurate MRI-histology comparison. Data S1 reports
additional demographical details and technical informa-
tion on our methodology.
MRI acquisition
All specimens were scanned on a 9.4 T Agilent small ani-
mal scanner using a 33 mm surface coil and a 1 T m1
gradient insert (temperature held constant at 35°C using
a temperature probe and an MRI-compatible air heater).
Structural images were acquired axially using a multi-
slice spin echo sequence, to define specific radiographic
positions for the subsequent histological procedures (reso-
lution 0.20 9 0.10 9 2.00 mm3, TE/TR = 20/614 msec).
Twenty 0.800 mm-thick diffusion-weighted slices were
acquired sagittally, parallel to the surface exposed by the
mid-sagittal cut, using a multi-slice spin echo sequence
(resolution: 0.16 9 0.20 mm2; field-of-view: 21 9 51.2
mm2; TE/TR = 39.5/2200 msec; d/D = 12/18 msec; 25
b = 0 images; six b-shells: b of 520, 2080, 4680, 8320,
13,000, 18,720 sec mm2 with 6, 15, 24, 33, 42, 51
isotropically distributed gradient directions).
MRI signal analysis
The NODDI model was fitted to the diffusion data voxel-
by-voxel in Matlab (The MathWorks, Inc., Natick, MA)
with the NODDI toolbox (http://nitrc.org/projects/nodd
i_toolbox), setting the free water diffusivity to that of the
buffer solution and the intrinsic diffusivity of the neural
tissue to 1.50 lm2 msec1 (as this value maximizes the
quality of the fit in all specimens). An additional com-
partment of isotropic restriction was employed, as in
other ex vivo studies.30
Model fitting provided maps of isotropic volume frac-
tion (IVF), neurite density index (NDI) and orientation
dispersion index (ODI) (Table 1). IVF is the volume frac-
tion of the water pool characterized by isotropic diffusion,
and can be interpreted as the voxel volume fraction of free
water, in this instance the buffer solution (cerebrospinal
fluid in vivo). NDI describes the volume fraction of
zero-radius cylinders, designed to describe axons and den-
drite. Therefore, it models the amount of neurites within a
voxels. ODI is obtained fitting a Watson distribution to the
zero-radius cylinder orientation distribution26, and is a
metric designed to characterize neurite orientation variabil-
ity, ranging from 0 (axon/dendrites all parallel) to 1 (axon/
dendrites isotropically randomly oriented).
For comparison, we also fitted the standard diffusion
tenor imaging (DTI) model31 to the measurements in
Gaussian diffusion regime (up to b = 4680 sec mm2)
using in-house Matlab code. From the fitted tensor,
Table 1. Summary and description of NODDI and histological metrics.








NDI NODDI Amount of neurites
Isotropic volume
fraction
IVF NODDI Amount of free water
Fractional
anisotropy
FA DTI Anisotropy of diffusion
profile
Axial diffusivity AD DTI Diffusivity along
principal tensor
direction
Radial diffusivity RD DTI Diffusivity across
principal tensor
direction
Mean diffusivity MD DTI Mean rate of diffusion




MSF Histology Amount of myelin
Neurofilament
staining fraction




ASF Histology Amount of astrocytes
Microglia staining
fraction
lGSF Histology Amount of microglia
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fractional anisotropy (FA), axial, radial, and mean diffu-
sivities (AD, RD, and MD) were obtained in each MRI
voxel. The relationship between NODDI and DTI metrics
has been investigated in detail in previous works.26,27 For
instance, a decrease in DTI FA can be caused indepen-
dently by a decrease in the density of axons or an increase
in the orientation dispersion.
Histological procedures
Optimized histological procedures6,32 were followed.
The four samples were dehydrated and embedded in
paraffin. Subsequently, 10 lm-thick sections were cut
with a microtome from the surface exposed by the pre-
liminary mid-sagittal cut. The position of the sections
within the sagittal MRI slices was inferred from the axial
scans, accounting for tissue shrinkage.
For each case, serial histological sections mapped to
two predefined MRI slices were stained for the following
(two sections per MRI slice per staining, 200 lm apart):
Palmgren silver staining and phosphorylated and non-
phosphorylated neurofilament immunostaining (neuronal
elements); myelin proteolipid protein (PLP) immunohis-
tochemistry (myelin); immunohistochemical labeling of
ionized calcium-binding adapter molecule 1 antigen
(Iba1+) (microglia); glial fibrillary acidic protein (GFAP)
immunohistochemistry (astrocytes).
Optical imaging
High-resolution digital images of the stained sections
were acquired with an Aperio slide scanner (ScanScope
AT Turbo) at a magnification of 4009. Data S2 shows
examples of images from all specimens.
Histological image processing
Histological images were processed in Matlab with the
StructureTensorToolbox (http://github.com/fragrussu/Struc
tureTensorToolbox) at a resolution of 1.008 9 1.008
lm2. Processing enabled the calculation of the following
features (Table 1) within patches matching the within-
slice MRI resolution (0.16 9 0.20 mm2): neurite orienta-
tion dispersion; fraction of material stained by each
immunohistochemical labeling method (Fig. 1).
Neurite orientation dispersion was quantified by patch-
wise circular variance (CV) of neurite orientations
(weighted-Watson model33). Neurites were identified on
the Palmgren images (4-cluster k-means segmentation34),
and their orientation calculated with structure tensor analy-
sis33,35 (spread of Gaussian kernels33: 1 lm). Similarly to
ODI, CV is an index ranging from 0 to 1, such that the
variability of neurite orientations increases as CV increases.
The immunolabeled post mortem material was seg-
mented with a 3-cluster k-means algorithm. Afterward,
patch-wise fractions of segmented material were calcu-
lated, obtaining four indices, ranging from 0 to 1
(Table 1): astrocyte staining fraction (ASF, from GFAP
images); microglia staining fraction (lGSF, from Iba1
images); myelin staining fraction (MSF, from PLP
images); and neurofilament staining fraction (NSF, from
neurofilament images).
MRI-histology co-registration
Histological images and patch-wise metrics were co-regis-
tered in Matlab to the corresponding MRI slices with a
landmark-guided nonlinear approach,36 which maximized
the Dice coefficient37 between the outlines of the speci-
mens in MRI and histology.38 Landmark points were
drawn on the mean b = 0 image and on the downsam-
pled histological images.
Region-of-interest outlining
Regional variation was assessed by studying different
regions-of-interest (ROIs), drawn manually on the mean
b = 0 images. Each ROI encompassed one particular tis-
sue type: gray and white matter, for controls; nonlesional
gray and nonlesional white matter, as well as lesions in
gray and white matter, for multiple sclerosis cases. ROI-
wise medians of co-registered NODDI and histological
metrics were extracted (values from the two histological
sections derived from each MRI slice were averaged).
Statistical analysis
We hypothesized that NODDI metrics are associated with
specific features of tissue microstructure, since NODDI
aims to disentangle key morphological factors contribut-
ing to the diffusion-weighted signal. We tested this
hypothesis by evaluating the statistical associations
between ROI-wise median values of NODDI and histolog-
ical indices, for a total of N = 48 ROIs (28 for the multi-
ple sclerosis cases; 20 for the controls), similar in number
to other studies.17,20
Firstly, we calculated Pearson’s correlation coefficients
between NODDI and histological metrics in multiple scle-
rosis and control cases in turn (significance level:
P < 0.05). Secondly, we fitted univariate multivariable lin-
ear regression models to quantify the sensitivity of each
NODDI metric toward each histological index. We chose
MRI indices as the dependent variables (in turn), since
one would use MRI as a noninvasive probe of the under-
lying, histological features. Histological indices were con-
sidered as the predictors of the MRI metrics, as
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Figure 1. Examples of features in normal control samples from histological images. In the first column, an example of each staining from the
upper lumbar control sample is shown. In the central and left columns, examples of raw image patches (160 9 200 lm 9 lm) from gray and
white matter are pictured beside the result of the image processing. Specifically, image processing provided estimates of local neurite orientation
(Palmgren silver staining) and segmentations of the stained material for the immunostains (PLP, neurofilaments, GFAP and Iba1+). Neurite
orientations were used to evaluated patch-wise orientation dispersion (metric CV), while the segmented areas to quantify patch-wise staining
fraction (MSF, NSF, ASF, lGSF).
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neuropathological analyses capture the micro-architectural
substrates of the MR signal. We fitted five linear regres-
sion models (Table 2) in controls and multiple sclerosis
cases in turn as follows.
1 Model number 1 is the most general. It employs all his-
tological features as predictors.
2 Model number 2 considers only metrics related to neu-
rons (CV, MSF, NSF) as predictors of each NODDI
index. From model number 2, two more models were
obtained: model 3 and 4.
3 Model number 3 focusses on the joint dependence of
NODDI indices on density and dispersion of neuronal
elements (metrics NSF, CV). These two are key factors
contributing to the diffusion MRI signal,26 and it is rel-
evant to determine which is more important to explain
the variability in NODDI metrics.
4 Model number 4 was formulated to study specifically
demyelination and axonal/neuronal loss. The model
employs myelin and neurofilament density as predic-
tors, and allows the quantification of the sensitivity of
each MRI metric to each of these two.
5 Model number 5 evaluates the association between
NODDI metrics and features of the extra-neuronal
space (i.e., glial fractions ASF and lGSF). Comparing
the quality of fit of this model to that of model 2
assesses whether MRI metrics are more strongly related
to neuronal features or to features of the extra-neuro-
nal space.
Linear regressions were performed in R (https://www.
r-project.org/), obtaining standardized b-coefficients (as-
sociation with the histological metrics; significance level
P < 0.05) and adjusted coefficients of determination
(quality of fit). The correlations and the regressions were
also evaluated for standard DTI FA, AD, RD, and MD for
comparison.
Results
The key results of this paper are that:
1 Both MRI (ODI) and histology (CV) reveal a trend of
lower neurite orientation dispersion in multiple
sclerosis demyelinated lesions, indicative of reduced
geometrical complexity of the neurite architecture
2 NODDI is sensitive and specific to the underlying ori-
entation dispersion as measured by histology in post
mortem spinal cord tissue from multiple sclerosis and
nonneurological controls (significant association
between MRI and histological dispersion: P < 0.001).
Maps of quantitative metrics from NODDI
and histology
Quantitative MRI and histological metrics and examples
of ROIs are illustrated for control (Fig. 2) and multiple
sclerosis cases (Fig. 3).
Nonneurological control observations
Histological analysis of the upper thoracic and lumbar
cords of the two control cases did not show evidence of
gray or white matter demyelination.
In both specimens, NODDI IVF is similarly low in
both gray and white matter. In contrast, NDI is higher in
white compared to gray matter whereas the converse is
true for ODI. Histological staining fractions (MSF, NSF,
ASF, and lGSF) show little contrast between gray and
white matter. CV is higher in gray matter compared to
white matter. DTI metrics show known trends,36 such as
higher diffusion anisotropy in white as compared with
gray matter.
Multiple sclerosis observations: thoracic specimen
In the upper thoracic cord specimen, we observe a soli-
tary chronic inactive demyelinated white matter lesion
with a paucity of microglial inflammation, relative axonal
preservation, and associated astrogliosis. These observa-
tions are captured in the histological metrics wherein
MSF is decreased (myelin loss), lGSF is decreased (mi-
croglia reduction), ASF is increased (astrogliosis), and
NSF is unchanged (neurofilament preservation) in the
focal white matter lesion compared to nonlesional white
matter areas. CV is reduced within the focal demyelinated
white matter lesion compared to nonlesional areas reflect-
ing reduced variability in axonal orientations within the
lesion. NODDI MRI maps demonstrate increased IVF and
decreased NDI and ODI in this lesion compared to non-
lesional areas. DTI metrics show variations in FA (with
both areas of increase and of decrease), and increased
AD, RD, and MD.
In nonlesional areas, differences between gray and
white matter are observed with increased CV (histology),
increased ODI (MRI), and decreased NDI (MRI) in gray
Table 2. Linear regression models fitted in this study.
Model number Equation
1 m = b0 + b1 CV + b2 MSF + b3 NSF + b4 ASF
+ b5 lGSF
2 m = b0 + b1 CV + b2 MSF + b3 NSF
3 m = b0 + b1 CV + b2 NSF
4 m = b0 + b1 MSF + b2 NSF
5 m = b0 + b1 ASF + b2 lGSF
m stands for the generic NODDI (IVF, NDI, ODI) or
DTI (FA, AD, RD, MD) metric.
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Figure 2. Examples of quantitative maps from NODDI and histology in the control cases. Top: upper thoracic sample; bottom: upper lumbar
sample. From MRI: mean b = 0 image with manual regions-of-interest (A and N); IVF (amount of free water, B and O); NDI (neurite density index,
C and P); ODI (dispersion of neurite orientations, D and Q); FA (diffusion anisotropy, E and R); AD (diffusivity along principal tensor direction, F
and S); RD (diffusivity across principal tensor direction, G and T); MD (mean rate of diffusion, H and U). From histology: CV (dispersion of neurite
orientations: I and V); MSF (amount of myelin: J and W); NSF (amount of neurofilaments: K and X); ASF (amount of astrocytes: L and Y); lGSF
(amount of microglia: M and Z). The black areas especially visible in A (upper thoracic control) are artifacts due to distortions caused by the
proximity of residual air bubbles, which were masked out when visualizing the maps (B to H).
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Figure 3. Examples of quantitative maps from NODDI and histology in the multiple sclerosis cases. Top: upper thoracic sample; bottom: upper
lumbar sample. The meaning of the metrics is that same as figure 2, and it is summarized in figure 2 caption. From MRI: mean b = 0 image with
manual regions-of-interest (A and N); IVF (B and O); NDI (C and P); ODI (D and Q); FA (E and R); AD (F and S); RD (G and T); MD (H and U). From
histology: CV (I and V); MSF (J and W); NSF (K and X); ASF (L and Y); lGSF (M and Z). The black areas especially visible in N (upper lumbar
multiple sclerosis specimen) are artifacts due to distortions caused by the proximity of residual air bubbles, which were masked out when
visualizing the maps (O to U).
8 ª 2017 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Neurite Dispersion In Multiple Sclerosis F. Grussu et al.
compared to white matter as seen in controls. DTI met-
rics also show similar contrasts as those of controls in
nonlesional areas (quantitative maps not shown).
Multiple sclerosis observations: lumbar specimen
In the upper lumbar cord specimen, separate demyeli-
nated lesions in each of gray and white matter, are seen.
All lesions are chronic inactive demonstrating loss of
myelin and an absence of microglial inflammation. Dis-
similar to the upper thoracic cord specimen, the gray and
white lesions in the lumbar cord specimen show a signifi-
cant reduction in neurofilament density (reflecting axonal
loss) and an absence of pronounced astrogliosis. Quanti-
tative histological maps reflect these features with a
decrease in MSF (myelin loss), NSF (axonal loss), and
lGSF (microglia reduction) and no change in ASF (as-
trogliosis) in lesional compared to nonlesional areas
(Fig. 3). Despite the differences between thoracic and
lumbar cord specimens, CV is reduced within the lesional
compared to nonlesional areas once again reflecting
reduced neurite orientation variability within the lesion.
NODDI maps demonstrate a trend towards a decrease
(NDI and ODI) or increase (IVF) in focal lesions as com-
pared to surrounding nonlesional tissue. DTI maps show
changes in FA (decreased) and AD, RD, and MD (all
increased) in lesional areas, as compared to nonlesional
tissue.
In nonlesional areas, differences between gray and white
matter are observed in the quantitative histological index
CV, which decreases in gray compared to white matter as
is seen in controls. In the areas sampled, NODDI and DTI
maps (MRI) show that (1) IVF is uniformly low in nonle-
sional gray and white matter; (2) NDI is higher in nonle-
sional white compared to nonlesional gray matter and; (3)
ODI is higher in nonlesional gray than in nonlesional
white matter; (4) FA is lower in nonlesional gray than
nonlesional white matter; (5) diffusivities (AD, RD, and
MD) show contrast between nonlesional gray and nonle-
sional white matter, with the former often exhibiting
higher values of these metrics. Histological maps demon-
strate increased ASF (astrocyte density) in white compared
to gray matter. In contrast, measures of MSF (myelin),
NSF (neurofilament), and lGSF (microglia) are similar
between white and gray matter.
Scatter plots of voxel-wise values
We observe regional variation in NODDI ODI and of his-
tological metrics as illustrated by voxel-wise scatter plots
in control (Fig. 4) and multiple sclerosis cases (Fig. 5).
The plots show patterns that are in line with those
reported in the previous section: a trend towards reduced
ODI and CV of lesional gray/white matter as compared
by nonlesional tissue of the same type; higher orientation
dispersion in the gray matter than in the white matter of
control cases. Histological CV replicates well the contrast
in both controls and multiple sclerosis cases. In the upper
thoracic case, notably ASF values shows changes in their
distributions between lesional and nonlesional white mat-




ROI-wise scatter plots and Pearson’s correlation coeffi-
cients r (Fig. 6) reveal a strong association between ODI
and its histological counterpart CV, observed consistently
in control and multiple sclerosis cases.
We find a strong positive correlation between ODI and
CV in both control (r = 0.84; P < 0.001) and multiple
sclerosis cases (r = 0.60; P = 0.001), as well as a weaker
positive correlation with MSF in multiple sclerosis
(r = 0.40; P = 0.036). A negative correlation is seen
between NDI and CV (r = 0.78; P < 0.001) in controls,
as well as a strong positive correlation with MSF
(r = 0.74; P < 0.001), NSF (r = 0.56; P = 0.002) and a
weaker correlation with lGSF (r = 0.49; P = 0.009) in
multiple sclerosis cases. No significant correlations are
observed for NODDI IVF.
Regarding DTI metrics, a negative correlation is seen
between FA and CV (r = 0.73; P < 0.001) in controls,
as well as a positive correlation between FA and MSF
(r = 0.42; P = 0.025) and FA and lGSF (r = 0.40;
P = 0.033) in multiple sclerosis. AD shows a positive cor-
relation with CV (r = 0.51; P = 0.025) and lGSF
(r = 0.60; P = 0.005) in controls, and a negative correla-
tion with MSF (r = 0.75; P < 0.001), NSF (r = 0.64;
P < 0.001) in multiple sclerosis. RD is positively associ-
ated to CV (r = 0.65; P = 0.002) in controls, and nega-
tively associated to MSF (r = 0.61; P < 0.001), NSF
(r = 0.57; P = 0.001) and lGSF (r = 0.50; P = 0.006)
in multiple sclerosis. Lastly, MD shows a positive correla-
tion with CV (r = 0.62; P = 0.004) and lGSF (r = 0.47;
P = 0.035) in controls, and with MSF (r = 0.67;
P < 0.001), NSF (r = 0.61; P < 0.001) and lGSF
(r = 0.54; P = 0.003) in multiple sclerosis.
Linear regression
Significant associations from linear regression models are
listed below (as standardized beta coefficients; full results
available in Data S3). Overall, the association between
ODI and CV, in both controls and multiple sclerosis
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cases, is the strongest and most significant and consistent
among all detected associations.
1 Model number 1: in control cases, NDI is negatively
associated with CV (b = 0.785, P = 0.0004) and ODI
is positively associated with CV (b = 0.860, P < 105).
FA is negatively associated with CV (b = 0.763,
P = 0.002) while AD, RD, and MD are positively asso-
ciated with CV (b = 0.459, P = 0.019 for AD;
b = 0.638, P = 0.003 for RD; b = 0.590, P = 0.004 for
MD). AD is also associated with lGSF (b = 0.529,
P = 0.011). In multiple sclerosis cases, NDI is positively
associated with MSF (b = 0.677, P = 0.0002). ODI is
positively associated with CV (b = 0.711, P < 104),
and, to lesser extent, with NSF (b = 0.521, P = 0.013).
DTI metrics AD, RD and MD show a negative associa-
tion with MSF (b = 0.628, P = 0.0002 for AD;
b = 0.496, P = 0.013 for RD; b = 0.544, P = 0.004
for MD).
2 Model number 2: in controls, NDI and ODI show,
respectively a negative and positive association with CV
(NDI: b = 0.789, P = 0.0002; ODI: b = 0.838,
P < 105); FA shows a negative association with CV
(b = 0.708; P = 0.001); AD (b = 0.508; P = 0.026),
RD (b = 0.645; P = 0.002) and MD (b = 0.615;
P = 0.005) all show a positive association with CV. In
multiple sclerosis cases, NDI is negatively associated
with CV (b = 0.258, P = 0.043) and positively associ-
ated with MSF (b = 0.647, P < 104); ODI shows a
positive association with NSF (b = 0.403, P = 0.009),
weaker than that with CV (b = 0.673, P < 104). DTI
metrics AD, RD and MD all show negative associations
with MSF and NSF (AD: b = 0.578, P = 0.0002 with
MSF and b = 0.385, P = 0.008 with NSF; RD:
b = 0.446, P = 0.012 with MSF and b = 0.380,
P = 0.0317 with NSF; MD: b = 0.493, P = 0.003
with MSF and b = 0.397, P = 0.016 with NSF).
3 Model number 3: in control cases, NDI is negatively
associated with CV (b = 0.760, P < 0.0002) and ODI
is positively associated with CV (b = 0.830, P < 105).
DTI metric FA is negatively associated with CV
(b = 0.733, P = 0.0003), while DTI AD (b = 0.527,
P = 0.017), RD (b = 0.673, P = 0.001) and MD
(b = 0.640, P = 0.002) are positively associated with
CV. In multiple sclerosis cases, NDI is positively associ-
ated with NSF (b = 0.521, P = 0.004) and ODI is posi-
tively associated with CV (b = 0.697, P < 104) and,
Figure 4. Scatter plots of NODDI orientation dispersion (ODI) and histological metrics (CV in A and F; MSF in B and G; NSF in C and H; ASF in D
and I; lGSF in E and J). The plots are color-coded according to tissue type (tissue types also shown in Fig 2). Top: upper thoracic control sample
(A to E). Bottom: upper lumbar control sample (F to J). Green dots correspond to voxels from white matter, red from gray matter.
Figure 5. Scatter plots of NODDI orientation dispersion (ODI) and histological metrics (CV in A and F; MSF in B and G; NSF in C and H; ASF in D
and I; lGSF in E and J). The plots are color-coded according to tissue type (tissue types also shown in Fig 3). Top: upper thoracic multiple sclerosis
sample (A to E). Bottom: upper lumbar multiple sclerosis sample (F to J). Green dots correspond to voxels from nonlesional white matter; light
blue from lesional white matter; red from nonlesional gray matter; yellow from lesional gray matter (note that no lesional gray matter was
identified in the upper thoracic sample).
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to lesser extent, with NSF (b = 0.494, P = 0.0008).
DTI AD (b = 0.652, P = 0.0003), RD (b = 0.586,
P = 0.002) and MD (b = 0.625, P = 0.001) are all
negatively associated with NSF.
4 Model number 4: no significant associations between
NODDI and DTI metrics and histological NSF and
MSF are detected in controls. In multiple sclerosis
cases, NDI is positively associated with both MSF
(b = 0.610; P = 0.0002) and NSF (b = 0.288;
P = 0.050). AD, RD and MD are all negatively associ-
ated to MSF (AD: b = 0.579; P = 0.0001; RD:
b = 0.447; P = 0.009; MD: b =  0.494; P = 0.002)
and NSF (AD: b = 0.384; P = 0.006; RD:
b = 0.378, P = 0.025; MD: b =  0.396; P = 0.012).
5 Model number 5: no significant associations between
NODDI metrics and glial fractions ASF and lGSF are
detected in controls, while DTI AD (b = 0.632;
P = 0.004) and DTI MD (b = 0.501; P = 0.030) show
a positive association with lGSF. In multiple sclerosis
cases, NDI is positively associated with lGSF
(b = 0.508; P = 0.009), while AD (b = 0.581;
P = 0.002), RD (b = 0.527; P = 0.006) and MD
(b = 0.558; P = 0.003) are negatively associated to
lGSF.
Regarding the adjusted coefficients of determinations,
the following is observed.
NODDI metrics: for models 1 to 3, higher values of
the adjusted coefficients of determination for ODI and
NDI as compared to IVF are obtained (maximum/mini-
mum values: 0.740/0.566 for ODI; 0.630/0.286 for NDI;
0.332/0.051 for IVF). For model 4, very low values of
this coefficient are observed for ODI and IVF (control
cases: 0.010 for ODI, 0.194 for IVF; multiple sclerosis
cases: 0.137 for ODI, 0.008 for IVF) and NDI in control
Figure 6. Summary of pair-wise associations between MRI metrics (NODDI and DTI) and histological indices. Associations are reported as
Pearson’s correlation coefficients (indicated as r) and were evaluated separately for controls (orange) and multiple sclerosis cases (violet). Data
points represent median values within several regions-of-interest, outlined on the mean b = 0 MRI images after co-registration MRI-histology.
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cases (0.118), while a higher value is obtained for NDI
in multiple sclerosis (0.577). Finally, model number 5
provides low values of the adjusted coefficient of determi-
nation for both control and multiple sclerosis cases and
all NODDI metrics (maximum value for NDI in multiple
sclerosis cases of 0.184; minimum for NDI in control
cases of 0.068).
DTI metrics: the adjusted coefficients of determination
are of similar magnitude as those of NODDI indices (full
details in Data S4).
Discussion
Key findings
Our study tests the hypothesis that the variability of neu-
rite orientations is a biomarker of multiple sclerosis
pathology, and is motivated by recent findings demon-
strating that neurite morphology is a substrate of neural
function23,24 and is affected by multiple sclerosis.25
Through the combination of state-of-the-art histology33
and post mortem NODDI26,27 MRI, we show for the first
time that neurite orientation dispersion is a marker of
microstructural pathology, as it detects trends of reduced
geometrical complexity of neurite architecture within
multiple sclerosis lesions. In so doing, we report a hereto-
fore undescribed layer of complexity of multiple sclerosis
pathology. Also, we provide unequivocal evidence that
NODDI dispersion indices are histologically meaningful,
demonstrating their clinical viability since NODDI can be
set up in clinical systems.26,27
Patterns of quantitative metrics
We present quantitative maps (Table 1) from NODDI
(IVF, NDI, and ODI), DTI (FA, AD, RD, and MD) and
histology (CV, MSF, NSF, ASF, lGSF) at the same resolu-
tion and from the same locations (Figs. 2 and 3). We also
illustrate regional variation in orientation dispersion and
all histological metrics with scatter plots (Figs. 4 and 5),
which confirm observations from visual inspection.
In controls, NODDI NDI and ODI show contrast
between gray and white matter, in line with recent
in vivo results.27 NDI is higher in white matter than in
gray matter, while the opposite holds for ODI. The histol-
ogy-derived index of orientation dispersion, CV, confirms
the patterns exhibited by ODI: dispersion is higher in
gray than white matter, due to the established higher vari-
ability in dendrite orientations compared to axons. How-
ever, the histology-derived index of neuronal element
density, NSF, does not exhibit such a clear contrast
between gray and white matter. Several factors may
explain this observation. Neurofilament immunostaining
demonstrates neuronal cell bodies, potentially reducing
the gray/white matter contrast of NSF, while differences
in myelination between dendrites and axons may increase
the gray/white matter contrast of NDI. Regarding DTI
metrics, known contrasts are observed between controls’
gray and white matter.27,36
Multiple sclerosis specimens provide a unique opportu-
nity to evaluate several cytoarchitectural compositions,
including gray versus white matter in both nonlesional
and lesional (i.e., demyelinated) states. In nonlesional tis-
sue, NODDI metrics in gray and white matter follow a
similar pattern as that described in controls, as well as
those from DTI. In contrast, lesional matter shows
hypointense NDI and ODI maps and hyperintense IVF
relative to nonlesional areas, in line with recent findings
in vivo.39 DTI metrics highlight focal pathology as well,
with increased diffusivity and changes in FA, similarly to
what has been previously reported.36 Our results suggest
that quantitative diffusion MRI metrics are well posi-
tioned to detect areas of focal pathology in the spinal
cord.
We provide novel insight into the histological substrate
of NODDI metrics. Specifically, we show that ODI corre-
sponds well with histologically derived CV (representing
neurite orientation dispersion) and that NDI can differ
from histologically derived NSF (i.e., neurofilament stain-
ing fraction). The implications of these findings will be
discussed below.
NODDI ODI detection of reduced orientation disper-
sion in lesions confirmed by histological CV is a key find-
ing of this work. This observation suggests that within
areas of focal demyelination in the spinal cord, neurites
can have reduced orientation variability. In white matter,
this may reflect reduced collateral branching or morpho-
logical alterations of individual axons.40 In gray matter,
reduced orientation dispersion may imply reduction in
the complexity of dendritic arborisations. Reduced orien-
tation dispersion is entirely consistent with recent
research in multiple sclerosis, which has reported: reduced
dendrite branching in cortical gray matter25; reduced dif-
fusion-MRI cortical complexity41; increased cortical lesion
fractional anisotropy.42 Our work highlights how the
complexity of neurite composition can be altered not only
in the multiple sclerosis cortex, but also in the function-
ally relevant spinal cord. Notably, DTI FA also highlights
changes within certain parts of the focal lesion in the
upper thoracic case are in line with reduced dispersion
(i.e., increased FA). However, the upper lumbar multiple
sclerosis case highlights how in other cases FA is con-
founded by demyelination, as it decreases when NODDI
ODI and histological CV also decrease (note that a
decrease in dispersion would imply an increase in FA, for
fixed neurite density27). Hence, the strong dependence on
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other factors other than neurite dispersion makes DTI
metrics a poorer tool than NODDI ODI to measure
changes of neurite geometry complexity due to multiple
sclerosis pathology.
The relationship within focal lesions between NSF (his-
tological neuro-axonal density) and NDI (MRI-derived
neurite density) is complex. While NDI always decreases
within lesions, NSF does not necessarily behave similarly,
highlighting variable degrees of axonal loss in different
lesions (Fig. 2). In contrast, NDI always drops dramati-
cally within lesions, similar to myelin density MSF. This
finding is not surprising as NDI is a surrogate index
equivalent to NSF/(1–MSF)26,43 (post hoc analysis con-
firms a correlation between these two measures).
Although altered exchange of water between intra/extra-
axonal space (i.e., permeability)40,44 may have contributed
to the observed patterns of NDI, it is expected that varia-
tions of myelin density would also contribute. Myelin
water is virtually invisible in diffusion MRI due to very
short T2.45 When myelin is lost, the local T2 increases,46
effectively increasing the amount of MRI-visible water
and causing NDI to decrease.26
All in all, our work highlights how focal multiple scle-
rosis pathology can be characterized at a new level, via
analysis of heretofore unexplored features such as neurite
orientation dispersion. While innovative, our results are
certainly preliminary and should be interpreted with care.
Further research is required both ex vivo and in vivo to
substantiate our findings and study systematically the
prognostic value of dispersion measurements. Larger sam-
ple sizes will be required in the future to enable a better
characterization of the spatial distribution of dispersion
changes due to multiple sclerosis pathology. For instance,
a preliminary investigation reported as supplementary
material (Data S4) highlights how MRI metrics may be
able to detect pathology that extends from focal lesions in
the peri-plaque area. Yet, evidence from a larger number
of ex vivo specimens is required to confirm these changes
histopathologically, due to the inherent variability in the
labeling efficiency at very short spatial scales.
Statistical analysis
The main finding highlighted by correlation and linear
regression analyses is that NODDI ODI is sensitive and
highly specific to histologically derived neurite orientation
dispersion in the presence of multiple sclerosis-related
pathology. Furthermore, NODDI metrics are specific to
neurons and are not influenced by features of the extra-
neuronal space, such as density of glial cells. Importantly,
NODDI NDI offers sensitivity to the local density of
axon/dendrites but is also strongly influenced by
variations of myelination, limiting its interpretability
without the support of myelin mapping techniques. Fur-
ther, markers of histology do not relate to IVF, which is
not surprising given that IVF is an indicator of free water
and our histological samples are dehydrated in their
preparation.
In controls, the histological orientation dispersion CV
is the main explanatory factor of NODDI NDI and ODI,
resulting from its high gray/white matter contrast. In
multiple sclerosis, the statistical analysis reveals several
interesting observations. ODI shows a strong, positive
association with its direct histological counterpart CV.
ODI shows only a weak correlation with MSF in multiple
sclerosis cases (not confirmed by linear regression), likely
due to the similar contrast of the two between lesional
and nonlesional tissue. Additionally, ODI also shows a
weaker, positive association with NSF. The association of
ODI-NSF in multiple sclerosis may result from the similar
contrast between the two maps due to the presence of
lesions, or may reflect a concomitant effect of the disease,
which may alter the number of neurites while also chang-
ing their underlying geometry. Finally, linear regression
models confirm that NODDI NDI offers sensitivity to the
density of neuronal elements (positive association with
NDI-NSF in model 3), but is also strongly influenced by
the local amount of myelin.
The statistical analysis also shows important insight
into DTI metrics. Both correlation and linear regression
analyses confirm once more that DTI is very sensitive to
multiple sclerosis pathology, as shown by strong changes
of FA, AD, RD, and MD noticeable on simple visual
inspection.36 However, DTI metrics appear as surrogate
biomarkers of multiple sclerosis pathology with relatively
poor specificity, as they are jointly influenced by demyeli-
nation, neuroaxonal loss and even changes in the glial
component. Of note, no DTI metrics show association
with histology-derived dispersion (CV), unlike NODDI
ODI. This latter finding highlights how biophysical mod-
els such as NODDI have the potential of increasing the
specificity of imaging biomarkers towards unique mor-
phological features of neuronal tissue, and may be able to
open new windows for the characterization of pathology
at the neurite scale.
Confounding factors
Care was taken to consider the influence of confounding
factors. We verified that histological section thickness did
not vary between lesional and nonlesional tissue (data not
shown) and excluded areas of nonspecific staining with a
combination of manual and automatic segmentation to
calculate CV, given their potential to bias this metric.33
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Limitations
We acknowledge a number of limitations.
NODDI metrics were obtained with a nonclinical MRI
protocol and from ex vivo fixed tissue. Fixation can alter
tissue microstructure47,48; therefore, NODDI metrics as
shown here may not be fully representative of their
in vivo counterparts. Nevertheless, our results agree well
with preliminary findings in vivo,39,49 providing confi-
dence that the conclusions of this study will most likely
hold true in clinical scenarios. A recent study has high-
lighted changes of NODDI metrics in the spinal cord
in vivo, although at a different level and on a different
subtype of disease.29 Similar works highlight that for the
in vivo application of the NODDI technique signal-to-
noise ratio is a key factor, and careful optimization of the
sequence parameters is required in order to obtain reli-
able microstructural indices.
Also, we obtained 2D histological indices from tissue
sections whose thickness was considerably smaller than
that of the MRI slices (10 lm vs. 800 lm), to achieve a
satisfactory signal-to-noise ratio in MRI. To account for
this mismatch, we derived two different histological sec-
tions per MRI slice (200 lm apart), and averaged the his-
tological indices for analysis. Nonetheless, not all the
tissue that contributed to the MRI signal was sampled,
possibly explaining some of the differences between MRI
and histology.
Another limitation relates to the Palmgren silver
method, which impregnates neurites in black and sur-
rounding nonneural tissue in lighter shades of brown.
Most of these structures were removed with manual and
automatic segmentation, but it is possible that some may
have remained. Nevertheless, tests demonstrated that the
inclusion of nonspecific staining did not change the
between-tissue contrast (data not shown).
Furthermore, we also acknowledge that the number of
specimens employed in this study (i.e., four) is limited,
although results are compelling and exciting. Therefore,
further research is required to confirm the changes in
neurite dispersion due to multiple sclerosis pathology
reported here. Regarding the MRI-histopathology correla-
tions, it should be noted that each specimens offers the
possibility of investigating several different types of
cytoarchitecture, which were probed by drawing ROIs in
all types of tissue. Practically, this led to the construction
of a data set of 48 data points, whose size suffices to fit
the regression models and evaluate correlations (other
high-impact studies on MRI-histopathology correlation
relied on the same amount of data20 or even less17).
Regarding the NSF maps, neurofilament antigenicity
can be negatively affected by formalin fixation,6 which
may be at least in part responsible for some of the
heterogeneity shown in our neurofilament immunolabel-
ing. Our analysis accounted for spatial trends of intensity,
but residual nonuniformities may have led to the under-
estimation of the association NDI-NSF.
In this study we only considered a limited number of
metrics (NODDI and DTI) derived from MRI. It is possi-
ble that other indices, either from other diffusion tech-
niques19,43 or from other MRI modalities (relaxometry,
magnetization transfer techniques, susceptibility imaging
or others) may have shown even stronger histopathologi-
cal correlations. The main focus of this work was neurite
orientation dispersion. Our particular MRI implementa-
tion, based on one dispersion mapping technique among
many (NODDI), aimed to show that mapping this often
neglected feature of neuronal microstructure has strong
clinical potential.
Finally, we point out that this work shows the potential
utility of NODDI metrics, but also highlights some
caveats related to their interpretation. We stress that
NODDI metrics should always be interpreted with care:
NODDI indices are designed to measure geometrical fea-
tures of neurite morphology, but in practice they can be
influenced by other factors, as for example myelin for the
case of NDI.
Future directions
Future validation of our preliminary findings could
include: analysis of tissue from areas beyond the spinal
cord; extension of the histology to the third dimen-
sion50,51; further confirmation from in vivo data; charac-
terization of more complex morphological features of
glial cells52; more accurate diffusion MRI signal model-
ing43,53; analysis of other quantitative MRI metrics (such
as those from relaxometry, magnetization transfer tech-
niques or susceptibility imaging).
Conclusions
Our study identifies a novel sensitive and specific biomar-
ker of microstructural pathology in the multiple sclerosis
spinal cord: neurite orientation dispersion. Moreover, our
work highlights how a clinically viable quantitative MRI
method, NODDI, provides a histologically meaningful
measure of neurite dispersion that can be used to unravel
previously undetected layers of complexity of multiple
sclerosis pathology in the spinal cord. The in vivo appli-
cation of neurite orientation dispersion mapping has the
potential to not only cast light onto pathophysiological
processes relevant to multiple sclerosis, but also to pro-
vide a clinically sensitive outcome measure in clinical trial
and practice settings for prognosis and monitoring treat-
ment response.
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